ITEOS THERAPEUTICS, INC. UP TO $125,000,000 OF SHARES OF COMMON STOCK SALES AGREEMENTSales Agreement • May 10th, 2023 • iTeos Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
iTeos Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
